Health Care/Hospital

Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women's Health, Hematology

* There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to participate in their care * The partnership will initially focus on endometriosis and hematology; high-need therapeutic areas where patients are act...

2025-05-13 21:40 2334

FSP Group Showcases AI-Powered Power Solutions at COMPUTEX 2025, Empowering Smarter Applications with Comprehensive Upgrades

TAIPEI, May 13, 2025 /PRNewswire/ -- FSP Group, a global leader in power solution technology, will participate in COMPUTEX 2025 fromMay 20 to 23 at Taipei Nangang Exhibition Center Hall 1. Under the theme "Comprehensive Power Solutions for AI Era," FSP will unveil innovative power solutions acros...

2025-05-13 20:30 2501

iNtRON Seeks a Strategic Partner to Explore the Promising Market for MRSA Decolonization

* Aiming to Provide a Novel Solution Against Post-Operative MRSA Infections * Demonstrated its Efficacy and Safety through previous Clinical Trials * Company seeks global partners to co-develop toward Commercialization SEOUL, South Korea and BOSTON, May 13, 2025 /PRNewswire/ -- iNtRON Biotech...

2025-05-13 20:00 1702

Hyundai ADM Bio Voluntarily Withdraws IND for Clinical Study of Docetaxel Combination Cancer Therapy to Focus on Immunotherapy Strategy

Declares a strategic pivot to lead the post-patent immunotherapy combination era SEOUL, South Korea, May 13, 2025 /PRNewswire/ -- Hyundai ADM Bio (KOSDAQ symbol 187660) today announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical trial evaluating...

2025-05-13 19:47 1799

Strategic Partnership | Sanyou Bio and TransRecoBio Forge Strategic Alliance to Build a New Ecosystem for the Full Industry Chain

SHANGHAI, May 13, 2025 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals ( Shanghai) Co., Ltd. ("Sanyou Biopharmaceuticals") and TransRecoBio (Wenzhou) Biotechnology Co., Ltd. ("TransRecoBio") officially signed a strategic cooperation agreement. The two companies will integrate their core streng...

2025-05-13 18:00 2119

Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations

SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conference hosted by VCBeat at the Suzhou International Expo CentreMay 9-10th. Fa...

2025-05-13 15:00 1795

GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy

* GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in  the XPRIZE Healthspan competition among 600 registered teams from 58 countries * Selected as one of 8 teams to pitch at the XPRIZE Investor Summit in New York * The team is now competing for one of the largest prize...

2025-05-13 09:21 1920

United Imaging Expands its U.S. Portfolio with the FDA Clearance of the uAngio® AVIVA for Interventional X-Ray

uAngio AVIVA features the industry's first intelligent voice-assist system, helping medical staff use voice commands and stay focused on their procedures. HOUSTON, May 12, 2025 /PRNewswire/ -- United Imaging, a global manufacturer of modern medical imaging technology, announces that its first Int...

2025-05-13 00:00 2317

Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting

SHANGHAI, May 12, 2025 /PRNewswire/ -- Grit Biotechnology Co., Ltd. ("Grit Bio "), a clinical-stage biotech pioneering novel immunotherapies announced today that three research programs, in collaboration with Vitalgen BioPharma Co., Ltd. ("Vitalgen"), will be showcased in one oral presentation and...

2025-05-12 20:30 2196

AccurEdit Therapeutics to present at the 2025 Annual Meeting of the American Society of Gene & Cell Therapy

SUZHOU, China, May 12, 2025 /PRNewswire/ -- AccurEdit Therapeutics today announced that its three abstracts have been selected for presentation, including one oral presentation on ART001, at the upcoming American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting being held from May 13-17...

2025-05-12 20:00 2013

VUNO's AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications

* Early Regulatory Approval Accelerates Expansion Plans in Europe and the Middle East SEOUL, South Korea, May 12, 2025 /PRNewswire/ -- VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest risk management system VUNO Med®-DeepCARS®(DeepCARS...

2025-05-12 15:22 2938

Give the Gift of Health This Mother's Day with VARON Oxygen Solutions

NEW YORK, May 9, 2025 /PRNewswire/ -- As families prepare to honor the women who have given them everything, VARON Oxygen Concentrators is spotlighting a vital but often overlooked gift:the ability to breathe easier, live more fully, and regain independence. In celebration of Mother's Day, VARON ...

2025-05-12 12:18 2812

CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy

SHANGHAI, May 11, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces preliminary clinical data for CT0596, an allogeneic BCMA-targeted CAR-T developed using the THANK-u Plus™ platform. CT0596...

2025-05-12 08:00 2227

Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025

SHANGHAI, May 10, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-drivenclinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation onSKG1108, its investigational optogenetic gen...

2025-05-11 00:00 3608

Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China

SHANGHAI, May 9, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the development, manufacturing, and commercialization of its B7-H3 AD...

2025-05-09 18:00 7117

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

SHANGHAI, NANJING, China and SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BC...

2025-05-09 16:25 2669

EASWE A10 & B10 Electric Wheelchair Empowers Seniors & Disabled Individuals - No More Limited Mobility

LOS ANGELES, May 8, 2025 /PRNewswire/ -- EASWE , a forward-thinking mobility solutions company, is proud to introduce its latest innovations: theA10 and B10 electric wheelchairs. These two models ar...

2025-05-08 23:00 2072

Datasea Pre-Announces Estimated Third Quarter Revenue of approximately $51.9 Million, up approximately 164.6% Year-over-Year

Expects to Achieve Projected Annual Revenue of $90 Million BEIJING, May 8, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or "the Company"), aNevada-based digital technology company specializing in acoustics high-tech and 5G+AI multimodal digital innovations, today pre-announced its...

2025-05-08 21:30 4743

ForwardX Deploys 435 AMRs at Chery Automobile's Dalian Factory

Challenge Us to Move Your Parts — Solving Complex Automotive Intralogistics from Roof Systems to Car Doors BEIJING, May 8, 2025 /PRNewswire/ -- Tier 1 suppliers are under pressure to move more parts, more quickly, and with greater precision than ever before. As automotive manufacturing grows inc...

2025-05-08 21:00 2366

From Patient to Pioneer: jinIX Supports Nathan Ehrlich's Mission for Rare Disease Research

SAN FRANCISCO, May 8, 2025 /PRNewswire/ -- The  jinIX Foundation hosted a meaningful and inspiring gathering—not just to mark the launch of its non-profit initiative, but to honor Nathan Ehrlich, a young rare disease advocate whose courage and vision ...

2025-05-08 20:35 1995
1 ... 39404142434445 ... 308

Week's Top Stories